Arama

A Case of Tardive Dyskinesia Occurring in the Early Stage of Low-Dose Quetiapine in a Major Depression Patient

Alparslan Cansiz, Ferzan Taymur

( Psychiatry and Clinical Psychopharmacology 2020; 30: 196-198) DOI: 10.5455/PCP.20200313060130

Abstract Full Text ( PDF) Related Articles

When Do Psychiatric Patients Get Better? Timeline and Implications of Clinical Response to Treatment in Serious Mental Illness

Radu Paun, Alexandru Pavel, Matei Valentin

( Psychiatry and Clinical Psychopharmacology 2020; 30: 443-448) DOI: 10.5455/PCP.20200917051316

Abstract Full Text ( PDF) Related Articles

Turkish Validity & Reliability of The Quick Inventory of Depressive Symptomatology Adolescent Version (QIDS-A17-SR) In Comparison with The Beck Depression Inventory-II Among Late Adolescents

Berna Erdogmus, Hakan Arslan, Ebru Arslan, Haluk Mergen, Sibel Erturk, Ira H. Bernstein

( Psychiatry and Clinical Psychopharmacology 2016; 26: 303-309) DOI: 10.5455/bcp.20151221100426

Abstract Full Text ( PDF) Related Articles

Association between problematic internet use and suicidal behavior in adolescents with major depressive disorder

Ahmet Alpaslan, Ugur Kocak, Nusret Soylu, Kerem Coskun, Halil Guzel

( Psychiatry and Clinical Psychopharmacology 2015; 25: S140-S140)

Abstract Full Text ( PDF) Related Articles

Improvement of an atypical Kikuchi-Fujimoto disease (KFD) with antidepressant treatment: the first psychiatric approach to a KFD case

Murat Ozen, Mehmet Orum, Aysun Kalenderoglu, Murad Atmaca

( Psychiatry and Clinical Psychopharmacology 2019; 29: 107-109) DOI: 10.1080/24750573.2018.1431352

Abstract Full Text ( PDF) Related Articles

Reliability and validity study of the Turkish version of the remission from depression questionnaire

Ayşegül Kart, Erkut Zamki, Sibel Orsel, Hakan Turkcapar

( Psychiatry and Clinical Psychopharmacology 2019; 29: 354-360) DOI: 10.1080/24750573.2019.1635673

Abstract Full Text ( PDF) Related Articles

Executive functions and impulsivity in suicide attempter adolescents with major depressive disorder

Merve Onat, Neslihan İnal, Burak Baykara, Ayşegül Özerdem, Gonca Özyurt, Yusuf Ozturk, Ümit Şahin, Ayşegül Ildız, Berrin Kaptancık, Ceren Hıdıroğlu, Aynur Pekcanlar

( Psychiatry and Clinical Psychopharmacology 2019; 29: 332-339) DOI: 10.1080/24750573.2018.1541647

Abstract Full Text ( PDF) Related Articles

Simple peripheral markers for inflammation in adolescents with major depressive disorder

Halit Uçar, Şafak Eray, Duygu Murat

( Psychiatry and Clinical Psychopharmacology 2018; 28: 254-260) DOI: 10.1080/24750573.2018.1423769

Abstract Full Text ( PDF) Related Articles

Prevalence and clinical characteristics of major depressive disorder (MDD) without depressed mood in Koreans with MDD: results from the CRESCEND study

Seon-Cheol Park, Hong Oh, Jae-Min Kim, Tae-Youn Jun, Min-Soo Lee, Jung-Bum Kim, Hyeon-Woo Yim, Yong Park

( Psychiatry and Clinical Psychopharmacology 2017; 27: 435-438) DOI: 10.1080/24750573.2017.1367564

Abstract Full Text ( PDF) Related Articles

Vitamin D deficiency in depressive, anxiety and adjustment disorder

Efruz Pirdogan, Mihriban Varkal, Omur Gunday, Omer Ozer, Kayıhan Karamustafalıoğlu

( Psychiatry and Clinical Psychopharmacology 2015; 25: S43-S45)

Abstract Full Text ( PDF) Related Articles

Defining remission in depression: comparison of depression rating scales with remission from depression questionnaire

( Psychiatry and Clinical Psychopharmacology 2014; 24: S344-S344)

Abstract Related Articles

Efficacy and tolerability of escitalopram in depressed patients with end stage renal disease: an open placebo-controlled study

Aylin Ertekin, Pervin Erdem, Abdullah Erdem, Kemal Yazıcı, Şenel Tot, Ayşe Devrim, Bahar Taşdelen

( Psychiatry and Clinical Psychopharmacology 2012; 22: 23-30) DOI: 10.5455/bcp.20120215011558

Abstract Full Text ( PDF) Related Articles

The combination of antidepressant drug therapy and high-frequency repetitive transcranial magnetic stimulation in medication-resistant depression

Bahadir Bakim, Ugras Uzun, Oguz Karamustafalioglu, Basak Ozcelik, Gokay Alpak, Onur Tankaya, Yasemin Cengiz, Burcu Yavuz

( Psychiatry and Clinical Psychopharmacology 2012; 22: 244-253) DOI: 10.5455/bcp.20120807092434

Abstract Full Text ( PDF) Related Articles

Hyponatremia associated with escitalopram use in a young woman

Okan Çalıyurt, Seda Derici

( Psychiatry and Clinical Psychopharmacology 2011; 21: 156-160) DOI: 10.5455/bcp.20110706031715

Abstract Full Text ( PDF) Related Articles

Effect of citalopram versus escitalopram on quality of life in the treatment of the acute phase of major depressive disorder: a comparative, open-label study

Omer Aydemir, Hakan Ergün, Sermin Kesebir, Haldun Soygür, Cankat Tulunay

( Psychiatry and Clinical Psychopharmacology 2011; 21: 210-218) DOI: 10.5455/bcp.20110627111533

Abstract Full Text ( PDF) Related Articles

Therapeutic goals, clinical indicators and follow up in major depressive disorder

Omer Aydemir

( Psychiatry and Clinical Psychopharmacology 2011; 21: S1-S9)

Abstract Full Text ( PDF) Related Articles

Effect of lamotrigine treatment on liver enzymes in mood disorders: A retrospective study

Feridun Bülbül, Salih Selek, Haluk A. Savaş

( Psychiatry and Clinical Psychopharmacology 2008; 18: 189-193)

Abstract Full Text ( PDF) Related Articles

THE EFFECTS OF LATE PARTIAL SLEEP DEPRIVATION AND ANTIDEPRESSIVE DRUG TREATMENT TO REGIONAL CEREBRAL BLOOD FLOW IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SPECT STUDY

Servet Ebrinç, Cengiz Başoğlu, Vedat Yılmaz, Mesut Çetin, Yavuz Narin, Mehmet Ağargün

( Psychiatry and Clinical Psychopharmacology 2001; 11: 242-250)

Abstract Full Text ( PDF) Related Articles

The Clinical Efficacy of Fluvoxamine on Suicidal Ideation

Nesrin DİLBAZ, Verda BİTLİS, Giray ARIHAN, Selahattin ŞENOL, Demir TAN

( Psychiatry and Clinical Psychopharmacology 1995; 5: 39-45)

Abstract Full Text ( PDF) Related Articles

Mood disorders Role of nesfatin-1 on impaired appetite in patient with major depressive disorder

( Psychiatry and Clinical Psychopharmacology 2013; 23: S274-S275)

Abstract Related Articles

Anxiety disorders Obsessive beliefs in patients with major depressive disorders

( Psychiatry and Clinical Psychopharmacology 2013; 23: S272-S272)

Abstract Related Articles

Mood disorders Relationship between treatment of selective serotonin reuptake inhibitors and alexithymia in patients with major depressive disorder

( Psychiatry and Clinical Psychopharmacology 2013; 23: S226-S226)

Abstract Related Articles

Clinical psychiatry Can plasma nesfatin-1 level predict major depressive disorder?

( Psychiatry and Clinical Psychopharmacology 2013; 23: S215-S215)

Abstract Related Articles

Dementia Assessment of neutrophil - Iymphocyte ratio in Alzheimer’s disease and major depressive disorder patients

( Psychiatry and Clinical Psychopharmacology 2013; 23: S207-S207)

Abstract Related Articles

Psychiatric genetics MicroRNAs as potential biomarkers for major depressive disorder

( Psychiatry and Clinical Psychopharmacology 2013; 23: S64-S65)

Abstract Related Articles

Effect of duloxetine on functional outcomes in patients with major depressive disorder

( Psychiatry and Clinical Psychopharmacology 2011; 21: -)

Abstract Related Articles

The Assessment of Cognitive Dysfunction in Major Depressive Disorder: A 16-Week Prospective Case-Control Study

Fikret Poyraz Çökmüş, Hüseyin Murat Özkan, Didem Sücüllüoğlu-Dikici, Kadir Aşçibaşi, Deniz Alçi, Neslihan Altunsoy, Erkan Kuru, Serra Yüzeren, Ömer Aydemir

( Psychiatry and Clinical Psychopharmacology 2021; 31: 25-33) DOI: 10.5152/pcp.2021.20148

Abstract Full Text ( PDF) Related Articles

Differential Diagnosis Findings Between Alzheimer’s Disease and Major Depressive Disorder: A Review

Ricardo Silva dos Santos Durães, Juliana Emy Yokomizo, Fabiana Saffi, Cristiana Castanho de Almeida Rocca, Antonio de Pádua Serafim

( Psychiatry and Clinical Psychopharmacology 2022; 32: 80-88) DOI: 10.5152/pcp.2022.21133

Abstract Full Text ( PDF) Related Articles